Wearables vs Traditional Monitoring
Can a smartwatch really catch the same heart problems a hospital-grade monitor does? When comparing wearables vs traditional monitoring, the short answer is: for one specific condition, atrial fibrillation, the evidence says yes, often. For most other clinical uses, it's more complicated. Here's what the actual research shows, not marketing claims from either side.
The Headline Number: AF Detection Accuracy
A systematic review covering 5 studies and 1,133 participants found wearable ECG devices detecting atrial fibrillation with:
| Metric | Range Found |
|---|---|
| Sensitivity | 83% to 100% |
| Specificity | 79% to 100% |
A separate meta-analysis focused specifically on Apple Watch ECG found even higher pooled results: 96.99% sensitivity against 12-lead ECG as the reference standard. A 2021 review went further, concluding smartwatch technology is noninferior to 12-lead ECGs, Holter monitors, or patch ECGs for AF detection specifically.
This isn't just industry marketing. The 2023 ACC/AHA/HRS clinical guidelines recommend using consumer-accessible electrocardiographic devices, including smartwatches, for AF recurrence monitoring. That's a real endorsement from major cardiology bodies, not just a device manufacturer's claim.
Where the Numbers Get Weaker
The strong numbers above come with real conditions attached.
Unreadable Recordings Are Common
In one study of the Apple Watch Series 6, 27.9% of initial recordings were unclassifiable. Physician review brought that down to 1.6%, but that requires a clinician actually reviewing the data, not just the device working alone.
Why this matters for accuracy claims: when unclassifiable readings are excluded, sensitivity looks excellent (94.6%, specificity 100%). When those same unclassifiable readings are counted as wrong instead of excluded, sensitivity drops to 66.2% and specificity to 73.4%. Which number gets quoted depends heavily on how a study handles this, worth checking before trusting any single accuracy figure at face value.
Specificity Weakens for Non-AF Irregular Rhythms
The American College of Cardiology notes that while sensitivity and specificity for AF itself are very high, specificity for other arrhythmias with regular R-R intervals is notably poor. In plain terms: wearables are good at catching AF specifically, less reliable at correctly ruling out other, less common rhythm irregularities.
Where Wearables Genuinely Outperform Traditional Monitoring
- Continuous monitoring, not episodic. A Holter monitor typically records for 24-48 hours. A wearable can provide continuous monitoring for weeks, catching intermittent AF episodes a short Holter window might miss entirely.
- No clinic visit required. Traditional monitoring often means scheduling equipment pickup, wearing it, then returning for analysis. Wearables remove that friction entirely.
- Real-world data, not a snapshot. Patients wear their own device during normal daily life, not during an artificial short monitoring window.
Where Traditional Monitoring Still Wins
- Initial diagnosis in unclear cases. Guidelines endorse wearables for AF recurrence monitoring in already-diagnosed patients, not necessarily as the first diagnostic tool for an unclear presentation.
- Complex arrhythmias beyond AF. The evidence base for AF specifically is strong. For other, less common heart rhythm problems, traditional 12-lead ECG remains the more validated standard.
- No unclassifiable-reading problem. A properly placed 12-lead ECG doesn't have the ~28% initial unreadable-recording issue seen with some wearable devices.
The Data Only Matters If the Team Sees It
Wearable and remote monitoring data is only useful if it reaches the right person fast. HosTalky routes alerts to the right team member instead of everyone at once.
See How HosTalky WorksThe Bottom Line
For atrial fibrillation detection specifically, the evidence is genuinely strong enough that major cardiology guidelines now recommend wearables for recurrence monitoring. That's a real, earned clinical endorsement of smartwatch accuracy. But "noninferior for AF detection" isn't the same claim as "as good as traditional monitoring for everything," and the real-world accuracy numbers depend heavily on how unreadable recordings get handled, a detail that's easy to miss when a device's own marketing quotes only the best-case sensitivity figure.
For more on how remote monitoring is being deployed in real clinical settings, see our coverage of Hospital in the Home: how continuous remote monitoring is changing recovery care. If you're evaluating wearable devices generally, our 2026 wearable device rankings cover the current consumer options.
FAQs
Are wearables as accurate as a Holter monitor for detecting atrial fibrillation?
In many studies, yes, within a meaningful range. A systematic review of 5 studies covering 1,133 participants found smartwatch sensitivity for AF detection ranging from 83% to 100%, and specificity from 79% to 100%, compared to 12-lead ECG or Holter monitoring. A 2021 review concluded smartwatch technology is noninferior to 12-lead ECGs, Holter monitors, or patch ECGs for detecting AF.
What's the biggest limitation of wearable ECG monitoring?
Unreadable recordings. In one study, 27.9% of initial Apple Watch ECG recordings were unclassifiable, though physician review reduced this to 1.6%. When unclassifiable readings are counted as incorrect rather than excluded, sensitivity can drop sharply, from 94.6% to 66.2% in one study. Specificity for irregular but non-AF heart rhythms is also notably weaker than for clear AF cases.
Do medical guidelines actually recommend consumer wearables?
Yes, with caveats. The 2023 ACC/AHA/HRS guidelines recommend using consumer-accessible electrocardiographic devices, including smartwatches, for AF recurrence monitoring. This is a real, current clinical guideline endorsement, not just industry marketing, though it applies specifically to recurrence monitoring in already-diagnosed patients, not as a replacement for initial diagnostic workup.
Sources and References
- Diagnostic Accuracy of Wearable ECG Devices for Atrial Fibrillation and ST-Segment Changes: A Systematic Review. PMC, 2025.
- Accuracy of Smartwatches in the Detection of Atrial Fibrillation: A Systematic Review and Diagnostic Meta-Analysis. JACC: Advances.
- Diagnostic Accuracy of Apple Watch Electrocardiogram for Atrial Fibrillation: A Systematic Review and Meta-Analysis. JACC: Advances.
- Smartwatches and Atrial Fibrillation: What Works and What Needs Improvement? American College of Cardiology, 2024.
